Clinical Trial Update: Optimizing Y90 Therapy for Radiation Lobectomy

View source ↗

Summary

Northwestern University sponsors a trial to optimize Y-90 radioembolization for radiation lobectomy in hepatocellular carcinoma to improve surgical outcomes for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 radioembolization (yttrium-90 microspheres)

Snippet

Sponsor: Northwestern University | Conditions: HCC, Resection | Status: RECRUITING